다우존스 지수

무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

등록

홈
인베스팅
주식
미국
NASDAQ
New River Pharmaceuticals (MM) (NRPH)
New River Pharmaceuticals (MM) (NRPH) 뉴스

NRPH

New River (NRPH)

New River Pharmaceuticals (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:NRPH

1 2 3 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2007/04/19	05:41	PR Newswire (US)	HealthShares(TM) Announces Changes to the HealthShares(TM) Neuroscience and Composite Indices	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/04/03	22:00	PR Newswire (US)	New River Pharmaceuticals Inc. Announces Convertibility of 3.50% Convertible Subordinated Notes Due 2013	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/03/19	23:00	PR Newswire (US)	New River Announces Expiration of Hart-Scott-Rodino Waiting Period	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/03/14	08:30	PR Newswire (US)	New River Pharmaceuticals Announces Year-End Results	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/02/24	07:07	PR Newswire (US)	Shire and New River Pharmaceuticals Announce FDA Approval of the First and Only Stimulant Prodrug VYVANSE(TM) (lisdexamfetamine	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/02/20	20:00	PR Newswire (US)	New River Pharmaceuticals to be Acquired by Shire plc for $64 per Share	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/02/06	00:18	PR Newswire (US)	New River Pharmaceuticals to Present at 2007 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Conference	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2007/01/26	05:01	PR Newswire (US)	James Shaffer Joins New River Pharmaceuticals as Vice President, Sales and Marketing	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/12/22	13:34	PR Newswire (US)	New River Pharmaceuticals and Shire Receive Approvable Letter for VYVANSE(TM) (lisdexamfetamine dimesylate) for the Treatment of	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/12/22	13:34	PR Newswire (US)	New River Pharmaceuticals and Shire Receive Approvable Letter for VYVANSE(TM) (lisdexamfetamine dimesylate) for the Treatment of	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/11/08	07:22	PR Newswire (US)	New River Pharmaceuticals Announces Third Quarter 2006 Results	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/10/30	23:00	PR Newswire (US)	Interim Results of a Phase III Trial of Lisdexamfetamine Dimesylate (NRP104/LDX) in ADHD Presented at Major Scientific Meeting	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/10/13	22:45	PR Newswire (US)	New River Pharmaceuticals Conducts End-of-Phase II Meeting with FDA for NRP290	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/10/07	10:25	PR Newswire (US)	FDA Issues Approvable Letter for NRP104 (lisdexamfetamine dimesylate) for the Treatment of ADHD	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/10/07	10:23	PR Newswire (US)	New River Pharmaceuticals Inc. Receives Approvable Letter for NRP104	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/10/04	06:20	PR Newswire (US)	Dr. Garen Manvelian Joins New River Pharmaceuticals as Chief Medical Officer	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/09/13	04:00	PR Newswire (US)	New River Pharmaceuticals Inc. Meets Enrollment in NRP104 Adult Phase III Study	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/09/09	06:38	PR Newswire (US)	New River Pharmaceuticals to Present at the Bear Stearns 19th Annual Healthcare Conference	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/08/18	07:03	PR Newswire (US)	New River Pharmaceuticals Names Dr. Samir Roy Vice President, Formulation and Manufacturing	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/08/09	06:46	PR Newswire (US)	New River Pharmaceuticals Announces Second Quarter 2006 Results	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/07/26	05:58	PR Newswire (US)	New River Pharmaceuticals Announces Exercise of Co-Promotion Option in the U.S. for NRP104	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/07/26	01:57	PR Newswire (US)	New River Pharmaceuticals Closes Sale of $135,000,000 Convertible Subordinated Notes	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/07/24	22:41	Business Wire	AMRI Announces Long-Term Manufacturing Agreement with New River Pharmaceuticals	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/07/20	10:06	PR Newswire (US)	New River Pharmaceuticals Prices $125 Million Convertible Subordinated Notes; Company to Repurchase Up to $51 million in Common	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/07/19	06:26	PR Newswire (US)	New River Pharmaceuticals Announces Proposal to Offer $125 Million Convertible Subordinated Notes; Company to Repurchase up to	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/06/30	23:31	PR Newswire (US)	New River Pharmaceuticals Announces Filing of Investigational New Drug Application for NRP409	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/06/24	01:52	PR Newswire (US)	New River Pharmaceuticals to Host Conference Call on A01, A02 and A03 Clinical Abuse Liability Studies of NRP104	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/06/21	06:30	PR Newswire (US)	New River Pharmaceuticals Provides Detail on A02 Clinical Abuse Liability Study of NRP104	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/06/19	06:45	PR Newswire (US)	New River Pharmaceuticals Provides Detail on A01 Clinical Abuse Liability Study and Announces Results from A03 Study	NASDAQ:NRPH	New River Pharmaceuticals (MM)
2006/06/14	22:01	PR Newswire (US)	New River Pharmaceuticals to Present Results from NRP104 Abuse Liability Studies	NASDAQ:NRPH	New River Pharmaceuticals (MM)

검색 관련기사 보기:NASDAQ:NRPH

1 2 3 다음 >>

Financial Select Sector

Verizon Communications

Gold vs US Dollar

BNP Paribas (QX)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관